Thomas Trimarchi - 16 May 2025 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role: President and CFO
Signature: /s/ Thomas Trimarchi
Issuer symbol: BBIO
Transactions as of: 16 May 2025
Transactions value $: -$721,367
Form type: 4
Filing time: 20 May 2025, 17:07:22
Previous filing: 21 Mar 2025
Next filing: 19 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Trimarchi Thomas	President and CFO	C/O BRIDGEBIO PHARMA, INC., 3160 PORTER DR., SUITE 250, PALO ALTO	/s/ Thomas Trimarchi	20 May 2025	0002030813

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BBIO	Common Stock	Tax liability	-$721K	-21.3K	-4.07%	$33.84	502K	16 May 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 38,545 shares of Common Stock underlying the Reporting Person's Restricted Stock Units.